Background
==========

Tobacco use is a modifiable risk behaviour in oral disease development. Dental professionals are able to reduce the oral and overall disease burden related to tobacco by counselling their patients. To date, however, tobacco intervention practices by community dental professionals have been limited, and dental professionals may have not fully embraced opportunities for tobacco use interventions \[[@B1]\], although tobacco use cessation clinical activities have been developed in both dental and dental hygiene programs \[[@B2]\].

Within undergraduate dental education for tobacco use interventions, the most important facilitator is evidence of the effects of tobacco use on oral health \[[@B3]\], while screening guides an important visual tool of the effects of tobacco use on oral health, particularly mucosal lesions \[[@B4]\]. These activities have been mainly conducted in the United States, where dental professionals may have been aware of the detrimental effects of smokeless tobacco in the oral cavity in their daily practice \[[@B5]\]. However, they are now expanding globally based on evidence of the detrimental effects of smokeless tobacco in the United States and European countries \[[@B6],[@B7]\] and in Central Asia \[[@B8],[@B9]\].

Numerous epidemiological studies have shown the detrimental effects of smoking on oral health. The Surgeon General Report in 2004 summarized evidence regarding causality of the association between smoking and oral health \[[@B10]\]. Evidence is sufficient to infer a causal relationship with smoking for cancers of the oral cavity and pharynx, and periodontitis. Evidence is suggestive but not sufficient to infer a causal relationship between smoking and root-surface caries and between maternal smoking and oral clefts. Furthermore, smokers have more missing teeth than non-smokers \[[@B11]\]. Dentist awareness of evidence for the detrimental effects of smoking during actual dental practice may promote smoking cessation activity.

Characterization of dental care for smokers is likely an important factor in determining whether community dentists can actively participate in smoking cessation interventions in countries in which smokeless tobacco has rarely been used. Because smokers appear to experience dental disease more frequently than non-smokers, smokers were more likely to have more perceived dental needs compared with non-smokers \[[@B12]\]. However, smokers are less likely to report dental visits than non-smokers \[[@B13]\]. These contradictory findings hinder the evaluation of the characteristics of dental care for smokers in community dental clinics. To our knowledge, no study has compared dental care between smokers and non-smokers in community dental clinics. The aim of present study was to clarify the characteristic of dental care of smokers in community dental clinics Japan.

Methods
=======

Study design
------------

To examine the characteristics of dental care for smokers in community dental clinics, 1022 dentists were randomly selected from among general practitioner members of the Japan Dental Association. Each dentist was notified by mail prior to sending the survey. Dentists were provided with a survey form for data collection, a cover letter outlining instructions on how to complete the survey, and an addressed return envelope for returning the completed survey. The patient survey was conducted by each dentist on a designated day in February 2008. Non-respondents were asked to complete an identical survey in May or July 2008. Patients aged ≥20 years who received dental care from the dentist on the designated day were informed of the study protocol and asked by their dentist about their willingness to participate. The study protocol was approved by the Ethical Committee of Fukuoka Dental College (Ethics Approval no. 115).

Treated dental disease or patient encounters
--------------------------------------------

Dental care can be determined by examining treated diseases and patient encounters. Community dentists were asked to report on treated diseases and patient encounters on the survey day using a questionnaire that was identical to the Dental Clinic Questionnaire of the Patient Survey conducted in October 2005 by the Ministry of Health, Labour and Welfare of Japan \[[@B14]\], except for the items regarding smoking status. The treated diseases and encounters were presented as specific codes that are commonly used to describe dental diseases in the universal health insurance system in Japan.

Dentists were instructed to select one treated disease or encounter per patient that was principally responsible for the specific dental care on the survey day from a list consisting of 15 items in the questionnaire (Table [1](#T1){ref-type="table"}). For example, periodontal disease progression was presented as P~1~, P~2~ and P~3~, representing mild, moderate and severe periodontal disease, respectively. These codes were determined in accordance with the degree of alveolar bone resorption, probing pocket depth and tooth mobility, and are routinely used by community dentists in the universal health insurance system of Japan. Since subgroup analysis requires a sufficient number of patients in each category, the 15 original items were classified into 5 category groups to allow the estimation of characteristics of dental care for smokers, namely gingival/periodontal treatment (GPT), caries/endodontic treatment (CET), prosthetic treatment (PRT), periodical check-up/orthodontic treatment (POT), and other encounters/treatments (OET).

###### 

Summarization of items for treated diseases and encounters

  **Category used for analysis**                    **Treated disease and encounter recorded in the questionnaire**^**a)**^   
  ------------------------------------------------- ------------------------------------------------------------------------- -------------------------------------------------------------
  Gum/periodontal treatment (GPT)                   Early stage ^b)^                                                          Gingivitis
                                                                                                                              Mild to moderate periodontal disease ^c)^
                                                    Advanced stage ^b)^                                                       Severe periodontal disease ^c)^
  Caries/endodontic treatment (CET)                 Early stage ^b)^                                                          Dental caries
                                                    Advanced stage ^b)^                                                       Inflammation of dental pulp
                                                                                                                              Apical periodontitis
                                                                                                                              Periapical abscess and radicular cyst
  Prosthetic treatment (PRT)                        Prosthetic treatment                                                      
  Periodical check-up/orthodontic treatment (POT)   Dental examination ^d)^                                                   
                                                                                                                              Orthodontic treatment
  Other encounters/treatments (OET)                                                                                           Other periodontal diseases ^e)^
                                                                                                                              Other disorders of teeth and supporting structures
                                                                                                                              Other diseases of the oral region, salivary glands and jaws
                                                                                                                              Stomatitis and related lesions
                                                                                                                              Dental injuries

^a)^ Items were recorded in the questionnaire on the survey day into five categories for analysis.

^b)^ This category was used for analysis to compare the distribution of levels of treated diseases within the GPT and CET subpopulations.

^c)^ Periodontal disease progression was presented as P~1~, P~2~ and P~3~ in the questionnaire, representing mild, moderate and severe periodontal disease, respectively. These codes were adopted according to levels of alveolar bone resorption, probing pocket depth and tooth mobility, and are used by general dentists in the universal health insurance system of Japan.

^d)^ This category is mainly applicable to health check-ups.

^e)^ This category is mainly applicable to pericoronitis and gingival abscess.

Determination of smoking status
-------------------------------

The smoking status of patients was determined using a self-administered questionnaire and defined as follows: 1) 'current smoker', an individual who currently smokes and has smoked \>100 cigarettes in his/her lifetime; 2) 'former smoker', an individual who has previously smoked \>100 cigarettes, but does not currently smoke; and 3) 'non-smoker', an individual who has never smoked or who has smoked ≤100 cigarettes. The use of oral/smokeless tobacco was not assessed in this study because this type of tobacco is rarely used or sold in Japan, and was accordingly expected to have little impact on dental care among our study patients.

Statistical analyses
--------------------

The sampling strategy of dental patients consisted of two steps: selection of community dentists, and survey by each dentist of his or her individual patients. Under this complex survey design, community dentists were established as the primary sampling unit of the stratum in the analyses. Former smokers were excluded from analysis, since interpretation of the potential effects of former exposure to tobacco smoking would be difficult.

Analyses were conducted in two phases (Figure [1](#F1){ref-type="fig"}). Distribution of the five groups of treated disease and encounters was compared for smoking status by constructing a 5 × 2 contingency table using the chi-square test (Phase 1 analysis). When a significant difference was detected, five 2 × 2 contingency tables were constructed to test which group(s) of treated disease and encounter significantly contributed to the difference using the chi-square test. For this analysis, the significance level was shared at P \< 0.01 by the Bonferroni correction, since comparison was repeated five times.

![**Analyses of the differences in dental care between current smokers and non-smokers.** Analyses in the present study were conducted in two phases, namely difference in the distribution of treated diseases or encounters (phase 1 analysis), and stage of disease progression (phase 2 analysis). When a significant difference was detected in overall distribution (**a**), five additional 2 × 2 contingency tables were prepared to estimate which group of treated diseases and encounters contributed to the difference in distribution by smoking status (**b**).](1617-9625-11-13-1){#F1}

In accordance with the level of progression of treated disease, the GPT and CET patients were further divided into two subgroups during the phase 2 analysis (Table [1](#T1){ref-type="table"}). The distribution of smoking status in the GPT and CET subpopulations was tested according to progression of the treated disease (Figure [1](#F1){ref-type="fig"}). Logistic regression models were constructed for analysis of the GPT and CET subpopulations. In the GPT model, dependent variables were defined in a binary fashion, namely patients treated for early stage disease (gingivitis and mild and moderate periodontal diseases) = 0, and those treated for advanced stage disease (severe periodontal disease) = 1; and in the CET model, patients who were treated for early stage disease (dental caries) = 0, and those treated for advanced stage disease (inflammation of dental pulp, apical periodontitis, periapical abscess, and radicular cyst) = 1. When a significant interaction of smoking with gender or age group (20--39 years, 40--59 years and ≥60 years) was detected, the effect of smoking on the stage of treated disease was examined by constructing models stratified by gender/age groups. Adjusted odds ratios (ORs) and 95% confidence intervals (95% CI) were calculated according to smoking status and the stage of treated disease by adjusting for gender/age groups.

The potential effect of dentist clustering was adjusted for using statistical software (IBM SPSS Complex Samples 20.0, IBM Corp., New York, NY, USA). Significance level was set at P \< 0.05, except for the tests of multiple comparisons (P \< 0.01).

Results
=======

Of the 1,022 dentists that were mailed, 753 (73.7%) responded to the survey. These dentists provided records for 14,187 patients, while those of 2,912 were excluded because of incomplete information. Smoking rate was measured at 25.1% (2,835/11,275). Former smokers (n = 1,590) were not included in the analyses. Finally, the data of 2,835 current smokers and 6,850 non-smokers were used to evaluate characteristics of dental care for smokers vs. non-smokers in community dental settings in Japan (Table [2](#T2){ref-type="table"}).

###### 

Number of non-smokers and current smokers by gender and age groups

  **Factor and category**    **Number of patients**         
  ------------------------- ------------------------ ------ ------
  Gender                                                       
    Male                              1621            1944   3565
    Female                            5229            891    6120
  Age group (years)                                            
    20--39                            1425            889    2314
    40--59                            2055            1122   3177
    ≥60                               3370            824    4194
  Total                               6850            2835   9685

Former smokers (n = 1590) were not included in the analysis.

Table [3](#T3){ref-type="table"}, depicts the distribution of treated diseases and encounters by smoking status in the phase 1 analysis. CET accounted for nearly half of treatments and encounters (44.6%), followed by GPT (28.4%) and PRT (19.9%). The overall distribution of the five groups significantly differed by smoking (P = 0.001). The ad hoc test for each group showed significant difference in CET (P = 0.002) and POT (P = 0.001) by smoking, with current smokers more likely received CET than non-smokers and less likely to receive POT, though the differences were relatively small (47.1% vs. 43.6% and 1.6% vs. 2.7%, respectively). In contrast, proportions of GPT, PRT and OET was almost equivalent between portions of GPT, PRT and OET was almost equivalent between non-smokers and current smokers (28.8% vs. 27.7%, 20.3% vs. 19.0%, and 4.6% vs. 4.7%, respectively).

###### 

Distribution of treated diseases and encounters by smoking status

  **Group according to treated disease and encounter**    **Total % (n)**   **Smoking status**   **P-value**          
  ------------------------------------------------------ ----------------- -------------------- ------------- ------- -------
  Gum/periodontal treatment (GPT)                           28.4 (2755)        28.8 (1971)       27.7 (784)    0.001   0.299
  Caries/endodontic treatment (CET)                         44.6 (4324)        43.6 (2988)       47.1 (1336)           0.002
  Prosthetic treatment (PRT)                                19.9 (1929)        20.3 (1389)       19.0 (540)            0.155
  Periodical check-up/ orthodontic treatment (POT)           2.4 (230)          2.7 (187)         1.6 (43)             0.001
  Other encounters/treatments (OET)                          4.6 (447)          4.6 (315)         4.7 (132)            0.902
  Total                                                     100 (9685)          100 (6850)       100 (2835)               

^a)^ Chi-square test for all groups.

^b)^ Chi-square test for each group. Five 2 × 2 contingency tables were prepared to test differences in distribution by smoking. Since comparison was repeated five times, significance level in this series was adjusted by Bonferroni correction, made by multiplying each p-value by 5. For convenience of interpretation, significance level was retained at P \< 0.05 throughout this table.

In phase 2 of the analysis for the GPT subpopulation, the participants age was identified as a significant factor (P = 0.005). Ad hoc analyses were then performed in the models stratified by age, at 20--39 years, 40--59 years, and more than 60 years (Table [4](#T4){ref-type="table"}), while the number of patients increased with age (n = 489, 958, and 1,308, respectively). While the proportion of advanced stage disease in current smokers and non-smokers (4.1% vs. 4.4%) was similar in the younger age group, current smokers in the older two groups were more likely to receive treatment for advanced stage disease than non-smokers (24.9% vs. 15.3% and 40.8% vs. 22.1%). These differences were significant, with ORs adjusted for gender in the two older age groups of 1.67 (95% CI: 1.10--2.56, P = 0.001) and 2.25 (95% CI: 1.62--3.11, P \<0.001). When the proportion was compared based on the entire patient population aged more than 40 years, GPT for advanced stage disease accounted for 6.0% (324/5,425) of non-smokers and 9.7% (195/1,946) of current smokers. Current smokers were not predominant among patients treated with advanced stage disease, at 48.3% and 31.9% in the 40--59 and older than 60 years age groups, respectively, and 37.6% for all patients aged 40 years or more (data not shown).

###### 

Proportion of patients treated in the advanced stage of gingival/periodontal disease progression

  **Age group**^**a)**^**(n) smoking status**    **Stage of treated disease**   **Proportion of advanced stage**^**d)**^**(%)**   **Adjusted odds ratio**^**e)**^**(95% CI)**  
  --------------------------------------------- ------------------------------ ------------------------------------------------- --------------------------------------------- -------------------
  20-39 years (489)                                                                                                                                                                      
  Non-smokers                                             305 (65.2)                               14 (66.7)                                          4.4                       1.00 (Reference)
  Current smokers                                         163 (34.8)                               7 (33.3)                                           4.1                       0.81 (0.30--2.19)
  Total                                                   468 (100)                                21 (100)                                                                              
  40-59 years (958)                                                                                                                                                                      
  Non-smokers                                             516 (66.3)                               93 (51.7)                                         15.3                       1.00 (Reference)
  Current smokers                                         262 (33.7)                               87 (48.3)                                         24.9                       1.67 (1.10--2.56)
  Total                                                   778 (100)                                180 (100)                                                                             
  ≥60 years (1308)                                                                                                                                                                       
  Non-smokers                                             812 (83.8)                              231 (68.1)                                         22.1                       1.00 (Reference)
  Current smokers                                         157 (16.2)                              108 (31.9)                                         40.8                       2.25 (1.62--3.11)
  Total                                                   969 (100)                                339 (100)                                                                             

^a)^ Because of significant interaction with age group (P = 0.005), logistic regression analysis was performed in three models stratified by age group.

^b)^ Patients treated for gingivitis and mild to moderate periodontal disease.

^c)^ Patients treated for severe periodontal disease.

^d)^ The proportion was compared by smoking status in the subpopulation receiving gingival/periodontal treatment in three age groups.

^e)^ Adjusted for gender.

In the analysis to test the distribution of CET level by smoking status (Table [5](#T5){ref-type="table"}), interactions with gender and age groups were not significant. Current smokers were more likely to receive treatment for advanced stage disease than non-smokers (54.1% vs. 49.2%), and the difference was significant, with an OR adjusted for age and gender of 1.39 (95% CI: 1.19--1.62, P \< 0.001).

###### 

Proportion of patients treated in the advanced stage of caries/endodontic disease progression

  **Smoking status**    **Stage of treated disease**   **Proportion of advanced stage**^**c)**^**(%)**   **Adjusted odds ratio**^**d)**^**(95% CI)**  
  -------------------- ------------------------------ ------------------------------------------------- --------------------------------------------- -------------------
  Non-smokers                       1519                                    1469                                            49.2                       1.00 (Reference)
  Current smokers                   613                                      723                                            54.1                       1.39 (1.19--1.62)

^a)^ Patients treated for dental caries.

^b)^ Patients treated for inflammation of the dental pulp, apical periodontitis, periapical abscess, and radicular cyst.

^c)^ The proportion was compared by smoking status in the subpopulation receiving caries/endodontic treatment.

^d)^ Adjusted for age and gender.

Discussion
==========

In this study, we compared treated diseases and encounters among individual patients in community dental clinics, and found that dental care for current smokers and non-smokers in this setting differed. Current smokers were significantly higher than non-smokers in distribution for CET, and lower for POT, and more likely received GPT for advanced stage disease than non-smokers in older age groups. Our hypothesis was that community dentists in countries in which smokeless tobacco products are rarely used may not realize the detrimental effects of smoking. Therefore, the principal concept to discuss the results should be focused on the characteristic of dental care provided for current smokers. Consideration should be given to health behaviour, particularly less frequent visits to the dentist, although unmet needs of dental treatment were beyond the scope of the present survey.

Our results showed that current smokers were more likely to receive CET and less likely to receive POT than non-smokers. This trend likely reflects the less effective oral hygiene behaviours of smokers \[[@B15]\] and their less frequent visits to dentists \[[@B9]\], respectively. However, since the differences in distribution between non-smokers vs. current smokers were relatively small, community dentists may not realize the significance of these differences in routine clinical settings.

Unexpectedly, we found that the distribution of GPT and PRT between current smokers and non-smokers was similar. If the effects of smoking on periodontal disease \[[@B16]\] and early tooth loss \[[@B17],[@B18]\] in the Japanese population are directly reflected in dental care, proportions of GPT and PRT in current smokers would be higher than those in non-smokers. Again, the less frequent visits by smokers \[[@B13]\] may be responsible for the similarity in proportions of GPT and PRT between current smokers and non-smokers. Because gingival bleeding is suppressed in smokers \[[@B19]\], smokers who were less likely aware of periodontal disease may less likely to visit dentists than non-smokers. Alternatively, certain cases receiving PRT would be attributable to a severe form of periodontal disease. Community dentists may not realize the detrimental effects of smoking from the distribution of treated diseases.

The characteristics of dental care for smokers due to the detrimental effect of smoking may be reflected within the GPT subpopulation, in which the proportions of treatment for advanced stage disease in the two older age groups were 15.3% vs. 24.9% and 22.1% vs. 40.8% for non-smokers vs. current smokers. Dental professionals may not recognize the detrimental effect of smoking since non-smokers were still dominant among patients receiving GPT for advanced stage disease, at 62.4% of patients aged more than 40 years, albeit that former smokers were excluded from analysis.

The characteristics of GPT in smokers may be less apparent when the proportion is compared among the entire patient population, 6.0% vs. 9.7%. The finding would be more clearly reflected in the practice of periodontists, who primarily treat periodontal patients. Among the 5,879 dentists who responded to the nationwide survey in 2009 (response rate, 59%), the ratio of dentists who reported items regarding smoking history in the medical questionnaire and who routinely asked about smoking status was about 30% for both; and although 90% agreed that dentists should advise their patients to quit smoking, only 20% actually do so \[[@B20]\]. Thus, community dentists may be unaware of the smoking status of their patients, and may not recognize the detrimental effect of smoking during GPT.

The deterioration of untreated dental caries often involves more severe destruction of tooth structure, which may require endodontic-related treatment. Smokers may be more likely to be treated for advanced stages of disease of the tooth structure, but this may also reflect the less frequent visits to dentists made by smokers \[[@B13]\]. However, the frequent need for CET in smokers is in part likely a reflection of the detrimental effects of smoking. The Surgeon General Report in 2004 concluded that evidence to infer the presence or absence of a causal relationship of smoking with coronal dental caries is insufficient \[[@B10]\], and the evidence that is available was based on epidemiological studies which did not address possible confounders, and inconclusive findings of salivary alteration. In other studies that controlled for possible confounders, however, dental caries were significantly and independently associated with smoking \[[@B21]-[@B25]\]. A cohort study design may allow the inference of causality \[[@B21]\], and the effects of exposure to tobacco contents on the growth and metabolism of *Streptococcus mutans*\[[@B26]\] and on the expansion of the dental caries area \[[@B27]\] may suggest biological plausibility. A mechanism which acts via this cariogenic microorganism is conceivable, since the effects of tobacco use on periodontal microorganisms \[[@B28],[@B29]\] has been recently added to the list of potential causal pathways \[[@B30]\]. These reports invite further studies to examine whether the potential effect of smoking on tooth structure may influence oral health inequalities.

Although current smokers experience tooth loss more frequently than non-smokers \[[@B17],[@B18],[@B31]\], the proportion of prosthetic treatments between smokers and non-smokers in the present study was equivalent. The significant association of smoking with increased risk of prosthetic dental restorations was independent of sociodemographic characteristics, including education and income \[[@B32]\]. Our findings regarding CET and GPT for advanced stage disease in these subpopulations likely warrants further study regarding the intensity of PRT. Studies of Japanese workers revealed that current smokers were more likely to incur higher dental care costs than never or former smokers \[[@B33]\]. The increased proportion of patients receiving care for advanced stage conditions in the CET and GPT subgroups suggests the need for more intensive treatment in smokers than non-smokers.

Several limitations of our study warrant mention. First, a relatively high proportion of patients (20%) was excluded due to incomplete data. However, the smoking rate among the excluded patients was similar to that of the included patients (24.3% vs. 25.1%; data not shown), suggesting that bias caused by the exclusion of data would be limited with respect to smoking. Second, there is no information about diagnosis and socioeconomic status in the present study. Since we looked into treatments rendered by the questionnaire, it is thus difficult to draw concrete conclusions about the exact diagnosis and prognosis. It is possible that there is significant unmeasured confounding by socioeconomic status. These variables should be included to compare diagnosis and prognosis between current smokers and non-smokers in community dental clinics. Third, the survey was conducted on a single day and may have been influenced by daily variations due to weather conditions or weekly periodicity. Any effect of this single-day sampling on the representativeness of dental patients might have been small, however, given that patient distribution for gender and age was similar to that in a patient survey conducted by the Japanese Ministry of Health, Labour and Welfare in October 2005.

Conclusions
===========

The association of smoking with type of dental care of CET and GPT severity would warrant the need for dental professionals to engage their patients smoking within clinical practice. The detrimental effects of smoking in dental care for smokers regarding the distribution of treatments and encounters and stage of disease at the time of treatment might not be clearly realized by dental professionals unless smoking status of all patients is identified.
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